Skip to content
10-Q

Quarterly Report

ENTRADA THERAPEUTICS, INC. TRDA

0001689375-25-000050

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 38.22M sh
Shares Diluted Q3 2025 · Sep 30, 2025 41.46M sh
Shares Diluted Q3 2025 · Sep 30, 2025 41.29M sh
Shares Diluted Q3 2025 · Sep 30, 2024 40.63M sh
Shares Diluted Q3 2025 · Sep 30, 2024 37.58M sh
Capex Q3 2025 · Sep 30, 2025 $1.25M
Capex Q3 2025 · Sep 30, 2024 $2.52M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$96.31M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$9.95M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $93.29M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $101.21M
Stockholders Equity Q3 2025 · Sep 30, 2025 $340.72M
Stockholders Equity Q3 2025 · Jun 30, 2025 $379.51M
Stockholders Equity Q3 2025 · Mar 31, 2025 $417.26M
Stockholders Equity Q3 2025 · Dec 31, 2024 $428.68M
Stockholders Equity Q3 2025 · Sep 30, 2024 $422.45M
Stockholders Equity Q3 2025 · Jun 30, 2024 $429.93M
Stockholders Equity Q3 2025 · Mar 31, 2024 $269.37M
Stockholders Equity Q3 2025 · Dec 31, 2023 $242.36M
Current Liabilities Q3 2025 · Sep 30, 2025 $24.02M
Current Liabilities Q3 2025 · Dec 31, 2024 $39.48M
Total Liabilities Q3 2025 · Sep 30, 2025 $72.18M
Total Liabilities Q3 2025 · Dec 31, 2024 $97.64M
Current Assets Q3 2025 · Sep 30, 2025 $338.26M
Current Assets Q3 2025 · Dec 31, 2024 $440.04M
Total Assets Q3 2025 · Sep 30, 2025 $412.9M
Total Assets Q3 2025 · Dec 31, 2024 $526.32M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.06
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.53
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.35
Eps Diluted Q3 2025 · Sep 30, 2024 $1.72
Eps Basic Q3 2025 · Sep 30, 2025 −$1.06
Eps Basic Q3 2025 · Sep 30, 2025 −$2.53
Eps Basic Q3 2025 · Sep 30, 2024 −$0.35
Eps Basic Q3 2025 · Sep 30, 2024 $1.79
Sga Expense Q3 2025 · Sep 30, 2025 $10.3M
Sga Expense Q3 2025 · Sep 30, 2025 $31.5M
Sga Expense Q3 2025 · Sep 30, 2024 $9.97M
Sga Expense Q3 2025 · Sep 30, 2024 $28.61M
Rd Expense Q3 2025 · Sep 30, 2025 $38.36M
Rd Expense Q3 2025 · Sep 30, 2025 $108.31M
Rd Expense Q3 2025 · Sep 30, 2024 $31.26M
Rd Expense Q3 2025 · Sep 30, 2024 $91.9M
Net Income Q3 2025 · Sep 30, 2025 −$44.13M
Net Income Q3 2025 · Sep 30, 2025 −$104.59M
Net Income Q3 2025 · Jun 30, 2025 −$43.1M
Net Income Q3 2025 · Mar 31, 2025 −$17.35M
Net Income Q3 2025 · Sep 30, 2024 −$14.03M
Net Income Q3 2025 · Sep 30, 2024 $64.5M
Net Income Q3 2025 · Jun 30, 2024 $55.03M
Net Income Q3 2025 · Mar 31, 2024 $23.5M
Operating Income Q3 2025 · Sep 30, 2025 −$47.05M
Operating Income Q3 2025 · Sep 30, 2025 −$115.69M
Operating Income Q3 2025 · Sep 30, 2024 −$21.66M
Operating Income Q3 2025 · Sep 30, 2024 $52.88M
Revenue Q3 2025 · Sep 30, 2025 $1.61M
Revenue Q3 2025 · Sep 30, 2025 $24.12M
Revenue Q3 2025 · Sep 30, 2024 $19.57M
Revenue Q3 2025 · Sep 30, 2024 $173.38M